Carmen Cracknell2 min read
Hameed Shuja3 min read
Martina Lindberg, Vasilka Lalevska1 min read
Julie DiMauro26 min listen
GRIP2 min read
Vlada Gurvich37 min listen

Could Texas’s recently enacted law SB 29 shape the contours of corporate law?
Alexander Barzacanos2 min read

The SEC chief touched on his plans to “Make IPOs great again,” review the costs of the Consolidated Audit Trail and PCAOB, and support crypto clarity.
Alexander Barzacanos2 min read

“What if we reimagined disclosure using large language models?”
Alexander Barzacanos1 min read

The A&D regime will apply to the admission to trading of qualifying cryptoassets on cryptoasset trading platforms that allow retail participation.
Sam Robinson | CMS, Yasmin Johal | CMS7 min read

Principal third-party disclosure mechanisms and the common pitfalls for pharmaceutical compliance and risk teams.

The SEC found fault with the firm for how it reported cardiovascular safety results to investors regarding its drug, Roxadustat.
Julie DiMauro3 min read

An in-depth look at EFRAG’s proposed changes to the ESRS 1 General Requirements Standard.

SEC’s observations regarding disclosure practices following reviews of crypto asset ETP filings.
Julie DiMauro2 min read